American Psychiatric Association President Dr. Jeffrey Lieberman on how government policies are out of sync with our country's medical needs.

Dr. Eric Topol talks with Dr. Paul Offit about his new book, which takes on the supplement and alternative medicine industries.

Dr. Frank Veith questions the sacred cow of seeking a second opinion for a risky procedure.

It has been said that people who use marijuana shouldn't receive transplants because they may have liver damage or they may not comply with medical regimens. Is it time to revisit that guideline?

Frank Veith tackles the difficult question of whether patients with asymptomatic carotid stenting should be treated interventionally.

In light of the recent neuropathy warning for fluoroquinolones by the FDA, Dr. Auwaerter offers his thoughts on the connection between antibiotics and neuropathy. Should clinical practice be changed?

Dr. Kathy Miller reports on the potential harm that may come as a result of CIGNA's new policy that no genetic testing will be covered unless the patient first sees a genetic counselor.

Dr. David Kerr reports on a plausible study suggesting a link between MMR-deficient colon tumors and response to bevacizumab in the adjuvant setting.

Dr. Maurie Markman reports provocative findings about the prevalence of comorbid conditions in women with ovarian cancer and what they mean to clinical trials -- and the patients enrolled in them.

Do the benefits of low-dose CT screening in former smokers really outweigh the risks? Pulmonologist Andrew Shorr, MD, MPH, offers his analysis of a recent study